The synthesis of chiral compounds
through dynamic kinetic resolution
has shown improved results with the presence of racemization. Integrating
the reaction media for biocatalytic kinetic resolution and base-catalyzed
racemization pose challenges in chiral separation due to its alkaline
environment. Base-catalyzed racemization of (R)-ibuprofen
ester has been separately studied in isooctane, isooctane–water,
and isooctane–DMSO media. A rapid racemization rate of (R)-ibuprofen ester was obtained in isooctane-DMSO medium
as compared with the other two media with racemization rate constants
(k
rac) of 0.292 and 0.001 h–1, respectively. An investigation carried out on sodium hydroxide
and Amberlyst A26 (OH– resin) as base catalysts
has shown that Amberlyst A26 gave a better performance compared to
that of sodium hydroxide. Additionally, the rate of racemization increases
at higher reaction temperatures, but shows otherwise at a higher concentration
of substrate. The kinetic model of the base-catalyzed racemization
was developed and experimentally validated. The model incorporates
two main contributing factors in the racemization reaction: a base
catalyst and initial substrate concentrations. Base-catalyzed racemization
was conducted in the proposed packed-bed reactor, where the racemization
rate was faster with an increased velocity of feed flow rate. The
absolute rate constants of racemization (k
abs) obtained were 0.112 and 0.275 h–1 for feed flow
rates of 0.6 and 1.2 mL·min–1, respectively.
The packed-bed reactor was then proposed to be coupled with a membrane
reactor as an integrated dynamic kinetic resolution reactor of chiral
compounds.